NASDAQ:AVRO
AVROBIO, Inc.
- Stock
Last Close
1.39
17/05 20:00
Market Cap
60.62M
Beta: 1.58
Volume Today
548.64K
Avg: 1.29M
PE Ratio
1.07
PFCF: −0.73
Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|
average inventory | -772.50K - | -1.84M 138.51% | -2.35M 27.60% | -2.63M 11.85% | -1.48M 43.60% | -134.50K 90.93% | |||
average payables | 433.50K - | 1.66M 281.89% | 3.37M 103.35% | 3.32M 1.51% | 3.08M 6.98% | 1.94M 37.26% | 205.50K 89.38% | ||
average receivables | 772.50K - | 1.84M 138.51% | 2.35M 27.60% | 2.63M 11.85% | 1.48M 43.60% | 134.50K 90.93% | |||
book value per share | -0.66 - | -1.43 116.05% | 9.09 736.33% | 6.78 25.44% | 7.02 3.60% | 3.95 43.70% | 1.72 56.43% | 2.13 23.36% | |
capex per share | -0.02 - | -0.14 476.32% | -0.06 57.63% | -0.03 43.74% | -0.06 76.65% | -0.01 89.37% | -0.00 97.06% | ||
capex to depreciation | -8.51 - | -4.82 43.36% | -1.86 61.32% | -0.98 47.71% | -1.76 80.40% | -0.19 89.46% | -0.01 93.01% | ||
capex to operating cash flow | 0.02 - | 0.05 108.14% | 0.02 51.86% | 0.01 49.14% | 0.03 110.75% | 0.00 89.06% | 0.00 95.39% | ||
capex to revenue | |||||||||
cash per share | 0.77 - | 0.37 52.40% | 9.40 2,452.01% | 6.82 27.47% | 7.17 5.19% | 4.42 38.32% | 2.12 52.16% | 2.21 4.23% | |
days of inventory on hand | |||||||||
days payables outstanding | 15.97 - | ||||||||
days sales outstanding | |||||||||
debt to assets | 0.07 - | 0.17 129.12% | 0.01 94.83% | ||||||
debt to equity | 0.09 - | 0.23 162.73% | 0.01 96.00% | ||||||
dividend yield | 0.26 - | ||||||||
earnings yield | -0.02 - | -0.04 70.97% | -0.21 461.30% | -0.13 36.99% | -0.23 79.79% | -0.71 203.90% | -3.41 378.57% | 0.20 105.87% | |
enterprise value | 210.61M - | 499.10M 136.97% | 97.40M 80.49% | 365.16M 274.92% | 245.03M 32.90% | -9.63M 103.93% | -44.05M 357.19% | -36.81M 16.42% | |
enterprise value over ebitda | -45.93 - | -27.66 39.76% | -2.11 92.39% | -4.82 128.70% | -2.04 57.69% | 0.08 103.98% | 0.42 415.33% | 0.52 24.02% | |
ev to operating cash flow | -63.55 - | -30.47 52.06% | -2.59 91.51% | -5.40 108.59% | -2.48 54.04% | 0.10 103.96% | 0.45 361.03% | 0.58 28.57% | |
ev to sales | |||||||||
free cash flow per share | -0.48 - | -1.04 116.32% | -2.94 183.73% | -2.52 14.09% | -2.76 9.38% | -2.34 15.09% | -2.23 4.96% | -1.42 36.37% | |
free cash flow yield | -0.02 - | -0.03 116.32% | -0.18 431.68% | -0.13 28.94% | -0.20 57.95% | -0.61 207.46% | -3.14 415.36% | -1.04 66.78% | |
graham net net | -0.67 - | -1.49 123.84% | 8.59 674.66% | 6.31 26.54% | 6.72 6.57% | 3.64 45.90% | 1.46 59.74% | 2.06 40.89% | |
graham number | 3.17 - | 6.09 92.19% | 26.57 336.59% | 20.03 24.63% | 22.75 13.57% | 15.63 31.26% | 9.70 37.99% | 3.61 62.75% | |
income quality | 0.71 - | 0.88 23.63% | 0.81 7.56% | 0.93 14.20% | 0.83 11.01% | 0.82 0.30% | 0.92 11.56% | -5.20 666.21% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | 530.54 - | -352.62 166.46% | -29.61 91.60% | ||||||
interest debt per share | 0.34 - | 0.41 18.21% | 0.07 81.78% | ||||||
inventory turnover | |||||||||
invested capital | 0.09 - | 0.23 162.73% | 0.01 96.00% | ||||||
market cap | 215.97M - | 505.06M 133.86% | 223.70M 55.71% | 552.21M 146.85% | 504.71M 8.60% | 164.99M 67.31% | 31.05M 81.18% | 60.61M 95.18% | |
net current asset value | -4.60M - | -23.85M 418.12% | 118.72M 597.82% | 181.20M 52.62% | 250.35M 38.16% | 164.78M 34.18% | 71.10M 56.86% | 93.91M 32.08% | |
net debt to ebitda | 1.17 - | 0.33 71.70% | 2.73 726.34% | 2.47 9.66% | 2.16 12.46% | 1.47 31.97% | 0.71 51.52% | 1.37 92.50% | |
net income per share | -0.67 - | -1.15 70.97% | -3.45 199.54% | -2.63 23.82% | -3.27 24.51% | -2.75 16.07% | -2.42 11.74% | 0.27 111.25% | |
operating cash flow per share | -0.48 - | -1.01 111.38% | -2.80 176.89% | -2.47 11.97% | -2.73 10.63% | -2.29 16.18% | -2.22 2.84% | -1.42 36.20% | |
payables turnover | 22.85 - | ||||||||
receivables turnover | |||||||||
research and ddevelopement to revenue | |||||||||
return on tangible assets | -0.86 - | -2.66 207.47% | -0.35 86.92% | -0.36 3.55% | -0.44 21.48% | -0.58 32.19% | -1.02 76.64% | 0.12 111.79% | |
revenue per share | |||||||||
roe | 1.02 - | 0.81 20.86% | -0.38 147.07% | -0.39 2.17% | -0.47 20.18% | -0.69 49.09% | -1.41 102.55% | 0.13 109.12% | |
roic | 1.01 - | 0.81 20.19% | -0.38 146.89% | -0.40 6.70% | -0.47 16.17% | -0.64 36.10% | -1.12 76.35% | -0.72 35.86% | |
sales general and administrative to revenue | |||||||||
shareholders equity per share | -0.66 - | -1.43 116.05% | 9.09 736.33% | 6.78 25.44% | 7.02 3.60% | 3.95 43.70% | 1.72 56.43% | 2.13 23.36% | |
stock based compensation to revenue | |||||||||
tangible asset value | -4.58M - | -23.14M 405.24% | 122.18M 628.13% | 186.01M 52.24% | 254.34M 36.73% | 169.48M 33.37% | 75.37M 55.53% | 94.74M 25.70% | |
tangible book value per share | -0.66 - | -1.43 116.05% | 9.09 736.33% | 6.78 25.44% | 7.02 3.60% | 3.95 43.70% | 1.72 56.43% | 2.13 23.36% | |
working capital | 4.49M - | 3.68M 17.88% | 119.41M 3,142.30% | 181.68M 52.15% | 250.63M 37.95% | 179.76M 28.28% | 87.56M 51.29% | 93.91M 7.25% |
All numbers in USD (except ratios and percentages)